GL1X · GenesisL1 explorer

MolNFT v1 · #147538 · protein

IRAK4 in complex with a type II inhibitor

6EGA · Interleukin-1 receptor-associated kinase 4: “IRAK4 in complex with a type II inhibitor”. X-ray diffraction, 3 ligands (J8A, CO, SO4), 3 pockets (best druggability 0.72). MolNFT v1 #147538 on GenesisL1: 3D structure, binding sites…

PDB
6EGA
Type
protein
Length
535 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Interleukin-1 receptor-associated kinase 4
EC
2.7.11.1
UniProt
Q9NWZ3
Ligands
J8A, CO, SO4
Pockets
3 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInterleukin-1 receptor-associated kinase 4 (EC 2.7.11.1)protein26642% helix, 15% strandQ9NWZ3
BInterleukin-1 receptor-associated kinase 4 (EC 2.7.11.1)protein26942% helix, 16% strandQ9NWZ3

Ligands and binding sites

  • J8A · 3-{2-[(cyclopropanecarbonyl)amino][1,3]thiazolo[5,4-b]pyridin-5-yl}-N-{4-[(piperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide · ligand · 2 copies · chains A, B
  • CO · Cobalt (II) ion · metal · 6 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14050.720.8352empty
24680.710.8142J8A
34250.700.8145J8A

Interfaces

1 interface between chains.

  • A–B · 692 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 6EGA · IRAK4 in complex with a type II inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.